Compumedics

Compumedics Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Compumedics (CMP.AX) as of Oct 17, 2026 is 3,086.45 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was -53.54 % — a change of -5,865.00% (higher).

Cash Conversion

3,086.45 %

YoY

-5,865.00%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Compumedics is 2026 3,086.45 % . Cash Conversion Rate (OCF/Net Income) of Compumedics was 2025 -53.54 % . It decreases by -5,865.00% higher compared to the previous year.

The Compumedics Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2019
127.89 AUD
Jan 1, 2020
-92.21 AUD
Jan 1, 2021
132.67 AUD
Jan 1, 2022
242.23 AUD
Jan 1, 2023
-0.80 AUD
Jan 1, 2024
-592.01 AUD
Jan 1, 2025
-53.54 AUD
Jan 1, 2026
3,086.45 AUD
The Compumedics Cash Conversion history
YEARCash ConversionYoY
3,086.45 %-5,865.00%
-53.54 %-90.96%
-592.01 %+73,866.74%
-0.80 %-100.33%
242.23 %+82.58%
132.67 %-243.88%
-92.21 %-172.10%
127.89 %+536.93%
20.08 %-69.67%
66.21 %-2.91%
68.19 %-38.99%
111.78 %+48.11%
75.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Compumedics Stock analysis

What does Compumedics do? Compumedics Ltd., headquartered in Melbourne, Australia, operates in the Health Care sector, specializing in the research, development, manufacture, and distribution of medical equipment. The company employs 135 full-time staff and serves global markets across the Americas, Australia, Asia Pacific, and Europe and the Middle East. Its product portfolio includes sleep diagnostic systems, clinical EEG systems, brain monitoring solutions, ultrasonic blood-flow systems, and technical support services. Key offerings encompass Somfit/Somfit Pro, Grael 4K PSG:EEG, and Compumedics Neuroscan for neurology applications and brain research technologies. Compumedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compumedics stock

Cash Conversion Rate (OCF/Net Income) of Compumedics is 3,086.45 % in 2026.

Cash Conversion Rate (OCF/Net Income) of Compumedics changed from -53.54 % to 3,086.45 %, representing a -5,865.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Compumedics since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Compumedics with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Compumedics

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Compumedics